INOINOVIO PHARMACEUTICALS, INC.vs its industry peers
A metric-by-metric comparison of INOVIO PHARMACEUTICALS, INC. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INO본 종목 | $181M#2 | — | 41.4x#10 | 2769.2x#5 | -70.0%#2 | 20.6%#5 | -132871.3%#5 | -1944.6%#10 | -243.9%#3 | — | -25.5%#1 | — |
| WHWK | $182M#1 | — | 1.0x#6 | 25.5x#2 | -72.5%#3 | 67.7%#2 | -1601.1%#3 | -11.3%#3 | — | — | — | — |
| TRDA | $178M#3 | — | 0.8x#4 | 7.0x#1 | -87.9%#4 | -319.0%#9 | -621.1%#1 | -61.6%#7 | — | — | -34.1%#2 | — |
| UPB | $176M#4 | — | 0.6x#3 | 61.6x#3 | 20.4%#1 | -128.4%#7 | -5618.8%#4 | -52.9%#6 | — | — | -87.6%#3 | — |
| ALXO | $176M#5 | — | 1.3x#7 | — | — | 24.6%#4 | — | -74.7%#8 | -84.4%#2 | — | — | — |
| CNTN | $170M#6 | — | 0.4x#1 | — | — | -194.5%#8 | — | -7.9%#2 | — | — | — | — |
| SION | $169M#7 | — | 0.6x#2 | — | — | -22.0%#6 | — | -28.3%#4 | — | — | — | — |
| ANTX | $168M#8 | — | 2.2x#8 | — | — | 31.5%#3 | — | -46.3%#5 | — | — | — | — |
| ORMP | $168M#9 | 1.0x#1 | 0.8x#5 | 84.2x#4 | — | 573.1%#1 | -754.4%#2 | 0.0%#1 | -4.4%#1 | — | — | — |
| CURX | $168M#10 | — | 35.1x#9 | — | — | -1068.8%#10 | — | -88.2%#9 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-11-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice